Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine-Carboplatin versus Gemcitabine-Cisplatin Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer

Sarah MH Einerhand, Anna J Black, Homayoun Zargar, Adrian S. Fairey, Colin P Dinney, Maria C Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobson, Jeffrey S Montgomery, Nikhil Vasdev, Evan Y Yu, Evanguelos Xylinas, Wassim Kassouf, Marc A. Dall’Era, Srikala S. Sridhar, Jonathan S McGrath, Jonathan Aning, Shahrokh F Shariat, Jonathan L. WrightAndrew C. Thorpe, Todd M Morgan, Jeff M. Holzbeierlein, Trinity J Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Petros Grivas, Jorge A Garcia, Andrew J Stephenson, Jay B Shah, Simak Daneshmand, Kamran Zargar-Shoshtari, P. E. Spiess, Bas W van Rhijn, Peter C. Black, L. S. Mertens

Research output: Contribution to journal › Article › peer-review

21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine-Carboplatin versus Gemcitabine-Cisplatin Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences